Rationing By Any Other Name
“Rationing By Any Other Name” – The New England Journal of Medicine
“Rationing By Any Other Name” – The New England Journal of Medicine
Cancer drugs have become increasingly expensive in recent years. No one blinks anymore when a new lung cancer or colon cancer treatment comes to market priced at more than $100,000 per patient. In part, we don’t blink because we have simply gotten used to such prices – the shock has worn off. Moreover, many of…
A while back, former FDA Commissioner David Kessler published an article in the New England Journal depicting what cereal boxes would look like if they provided people with useful health information. Here is a sample: What do you think?
Here is data from the CDC, on the percent of Americans without health insurance. It shows that Obamacare, for all its strengths and weaknesses, is definitely addressing one major problem in the US:
In a wonderful article on deep cave exploration, Burkhard Bilger shows how powerful comparison can be in putting an unfamiliar topic into context. He is describing the arduous work involved in deep cave exploration. He is describing the risks of being far, far inside the cave when a heavy rain on the surface begins to…
The first time scientists sequenced a person’s entire genome, it took more than a decade and cost hundreds of millions of dollars. Currently, such sequencing takes less than twenty-four hours and costs less than $5,000: To put that into perspective, Myriad Genetics charges $3,000 to test for mutations in just two genes associated with breast…
Here is a very interesting essay in the Arkansas Business Journal, which ties our research on physician patient conversations into a broader message about the importance of good communication in business. Glad to see our work is having an impact. Considering all of the technical advances and new complexities in marketing today (such as social,…